AI in Clinical Trials Market to Reach USD 6.71 Billion by 2030, Accelerated by Predictive Analytics and Recruitment Platforms

Mordor Intelligence has published a new report on the AI in Clinical Trials Market, offering a comprehensive analysis of trends, growth drivers, and future projections.

The AI in clinical trials market is anticipated to grow from approximately USD 2.14 billion in 2025 to an estimated USD 6.71 billion by 2030, with a strong CAGR of around 25.70% over the forecast period. This surge is driven by rising reliance on AI-driven tools across trial design, patient recruitment, data monitoring, and outcome prediction. As drug pipelines become more complex-spanning oncology, rare diseases, and immunotherapies-sponsors increasingly lean on AI to streamline operations, reduce timelines, and improve trial success rates.

Trials are evolving beyond manual and manual-intensive processes: algorithmic modeling, large language models, and advanced matching systems are enabling smarter trial planning and safer, faster execution. Regulatory guidance is also aligning behind validated AI tools, further encouraging adoption across biopharma.

Report Overview: https://www.mordorintelligence.com/industry-reports/ai-in-clinical-trials-market?utm_source=openpr

Key Trends

Data-Centric Recruitment and Matching
AI platforms such as TrialMatchAI use structured and unstructured patient data-electronic health records, physician notes, and biomarker profiles-to recommend relevant protocols. Adoption of these tools is helping reduce screening times and improve enrollment rates.

Increased Use of Predictive Analytics for Trial Design
Sponsors are deploying machine learning to forecast dropout risk, anticipated adverse events, and optimal dosing strategies. These analytics refine protocol parameters before trials launch, boosting efficiency and reducing downstream costs.

Rapid Growth in Oncology and Precision Medicine Trials
Oncology trials, especially those with biomarker focus or combination therapies, represent a major share of AI integration. Translational data and AI models support patient stratification, adaptive enrollment, and endpoint prediction across complex treatment regimens.

Emerging Generative AI Tools
Generative AI is being used to draft protocol documents, informed consent text, and trial scenarios. These tools are expected to cut down planning times significantly as sponsors explore structured generation for regulatory and trial materials.

Regional Expansion with Asia-Pacific Leading Growth
North America remains the largest region by market share due to established clinical research infrastructure and early tech adoption. However, Asia-Pacific is witnessing the fastest growth, fueled by expanding CRO/CDMO capabilities, cost-competitive sites, and growing trial volumes.

Market Segmentation

By Component Type

Software

Services

By Therapeutic Area

Oncology

Cardiovascular Diseases

Metabolic Diseases

Infectious Diseases

Other Therapeutic Areas

By Clinical Trial Phase

Phase I

Phase II

Phase III

Phase IV / Real-World Evidence

By Deployment Model

Cloud

On-Premise

Edge / On-Device

By End User

Pharmaceutical & Biotech Companies

Contract Research Organizations

Research & Academic Institutes

Medical Device Manufacturers

By Region:

North America

Europe

Asia‐Pacific

South America

Middle East & Africa

Explore Our Full Library of Healthcare Industry Research Reports

https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=openpr

Key Players

Notable organizations shaping the AI in clinical trials landscape include:

Medidata (Dassault Systèmes)

IQVIA

Unlearn.ai

Owkin

Saama Technologies

Partnerships between Big Pharma and AI startups are increasingly common. For example, AstraZeneca's collaboration with Immunai integrates single-cell immune profiling into trial biomarker discovery and dose selection workflows.

For more information, visit: https://www.mordorintelligence.com/industry-reports/ai-in-clinical-trials-market/companies?utm_source=openpr

Conclusion

The AI in Clinical Trials market is poised to expand from USD 2.14 billion in 2025 to approximately USD 6.71 billion by 2030, growing at a remarkable 25.70% CAGR. This growth is driven by rising demand for predictive recruitment tools, AI-enhanced protocol systems, and advanced analytics supporting outcome prediction.

Oncology and rare disease trials remain at the forefront of adoption, with CROs and sponsors deploying technology to improve trial success and reduce timelines. While North America leads in infrastructure and revenue share, Asia-Pacific is rapidly emerging through cost-efficient sites and digital innovation.

Industry Related Reports

Generative AI In Clinical Trials Market: The Generative AI In Clinical Trials Market report segments the industry into By Application (Data Generation, Clinical Trial Design, and more), By Technology (Variational Autoencoders (VAEs), Generative Adversarial Networks (GAN), and more), By End Users (Researchers and Scientists, Clinical Trial Sponsors and CROs, and more), and Geography (North America, Europe, Asia-Pacific, and more).

Get More Insights: https://www.mordorintelligence.com/industry-reports/generative-ai-in-clinical-trials-market?utm_source=openpr

Clinical Trial Patient Recruitment Services Market: The Clinical Trial Patient Recruitment Services Market Report is Segmented by Phase (Phase I, Phase II, and More), Therapeutic Area (Oncology, and More), Service Type (Patient Database & Feasibility Services, and More), Recruitment Channel (Investigator-Site Led, and More), Geography (North America, Europe, Asia-Pacific, The Middle East and Africa, and South America).

Get More Insights: https://www.mordorintelligence.com/industry-reports/clinical-trial-patient-recruitment-services-market?utm_source=openpr

Artificial Intelligence (AI) In Pharmaceutical Market: The Artificial Intelligence in Pharmaceutical Industry Market Report Segments the Industry Into by Technology (Machine Learning, Deep Learning, and More), by Type (Software Platforms, Services), by Application (Drug Discovery and Preclinical Development, Laboratory Automation, and More), Deployment Mode (Cloud-Based, and Hybrid), and Geography.

Get More Insights: https://www.mordorintelligence.com/industry-reports/artificial-intelligence-in-pharmaceutical-market?utm_source=openpr

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana - 500032, India

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

This release was published on openPR.